NCT00368303View on ClinicalTrials.gov

A Local Register Study For Major Depression Of Paroxetine Controlled Release

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

December 31, 2006

Conditions
Depressive Disorder, MajorMajor Depressive Disorder (MDD)
Interventions
DRUG

Paroxetine CR

DRUG

Paroxetine IR

Trial Locations (11)

100083

GSK Investigational Site, Beijing

100088

GSK Investigational Site, Beijing

100096

GSK Investigational Site, Beijing

210029

GSK Investigational Site, Nanjing

410011

GSK Investigational Site, Changsha

510370

GSK Investigational Site, Guangzhou

610041

GSK Investigational Site, Chengdu

650032

GSK Investigational Site, Kunming

710032

GSK Investigational Site, Xi'an

710061

GSK Investigational Site, Xi'an

071000

GSK Investigational Site, Baoding

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY